Authors : Shilpi Agarwal, Sugyani Satapathy, Mukta Prasad
DOI : 10.18231/j.ijooo.2021.059
Volume : 7
Issue : 3
Year : 2021
Page No : 289-293
Aims: This prospective drug trial was done to compare latanoprost versus combination therapy of latanoprost and timolol maleate.
Methods and Materials: Patient were screened for primary open angle glaucoma and grouped as per pharmacological drugs used and measured IOP baseline before initiation of study. Group I consisting all patients with latanoprost monotherapy and Group II consisting of patients already using either latanoprost or timolol. Further A,B & C was assigned as per IOP baseline.
Results: In group I (Monotherapy), 28 patients were completed the follow up. The mean baseline IOP was 27.4 millimeter of Hg with standard deviation of 2.59. After 12 weeks of study, mean IOP was 19.66 millimeter of Hg with SD of 2.76. Mean IOP difference from baseline was 7.4 millimeter of Hg. So fall of 27.3% in IOP from pre-treatment level. In group II (Combination therapy), 19 patients were completed the follow up. The mean baseline IOP was 27.35 millimeter of Hg with standard deviation of 2.6. After 12 weeks of study mean IOP difference from baseline was 8.1 millimeter of Hg with SD of 2.0 millimeter of Hg i.e. a fall of 29.63% in IOP from pre-treatment level.
Conclusions: Combination therapy fared slightly better that Latanoprost alone in overall pressure reduction.
Keywords: Prostaglandins, Glaucoma, Timolol, Beta adrenergic, Dual therapy